Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 ADAMTS13 antibody depletion by bortezomib in thrombotic thrombocytopenic purpura.

Literature DB >> 23281998

ADAMTS13 antibody depletion by bortezomib in thrombotic thrombocytopenic purpura.

Jake Shortt, Danielle H Oh, Stephen S Opat.

Abstract

Entities: Chemical Disease Gene

Mesh：

Substances：

Year: 2013 PMID： 23281998 DOI： 10.1056/NEJMc1213206

Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245

Keyword Cloud
Cited

× No keyword cloud information.

33 in total

Review 1. Thrombotic microangiopathies: a general approach to diagnosis and management.

Authors: Donald M Arnold; Christopher J Patriquin; Ishac Nazy
Journal: CMAJ Date: 2016-10-17 Impact factor: 8.262

2. Bortezomib decreases the magnitude of a primary humoral immune response to transfused red blood cells in a murine model.

Authors: Prabitha Natarajan; Jingchun Liu; Manjula Santhanakrishnan; David R Gibb; Lewis M Slater; Jeanne E Hendrickson
Journal: Transfusion Date: 2016-10-13 Impact factor: 3.157

3. Purtscher retinopathies: are we aiming at the wrong target?

Authors: I H Yusuf; S-L Watson
Journal: Eye (Lond) Date: 2013-04-05 Impact factor: 3.775

Review 4. Mechanisms of Autoantibody-Induced Pathology.

Authors: Ralf J Ludwig; Karen Vanhoorelbeke; Frank Leypoldt; Ziya Kaya; Katja Bieber; Sandra M McLachlan; Lars Komorowski; Jie Luo; Otavio Cabral-Marques; Christoph M Hammers; Jon M Lindstrom; Peter Lamprecht; Andrea Fischer; Gabriela Riemekasten; Claudia Tersteeg; Peter Sondermann; Basil Rapoport; Klaus-Peter Wandinger; Christian Probst; Asmaa El Beidaq; Enno Schmidt; Alan Verkman; Rudolf A Manz; Falk Nimmerjahn
Journal: Front Immunol Date: 2017-05-31 Impact factor: 7.561

Review 10. The Tao of myeloma.

Authors: Lawrence H Boise; Jonathan L Kaufman; Nizar J Bahlis; Sagar Lonial; Kelvin P Lee
Journal: Blood Date: 2014-09-18 Impact factor: 22.113

ADAMTS13 antibody depletion by bortezomib in thrombotic thrombocytopenic purpura.

Review 1. Thrombotic microangiopathies: a general approach to diagnosis and management.

2. Bortezomib decreases the magnitude of a primary humoral immune response to transfused red blood cells in a murine model.

3. Purtscher retinopathies: are we aiming at the wrong target?

Review 4. Mechanisms of Autoantibody-Induced Pathology.

Review 5. How I treat refractory thrombotic thrombocytopenic purpura.

Review 6. Pathophysiology of thrombotic thrombocytopenic purpura.

7. Bortezomib-based antibody depletion for refractory autoimmune hematological diseases.

8. Bortezomib for Refractory Immune-Mediated Thrombocytopenia Purpura.

9. Bortezomib therapy for nephrotic syndrome due to idiopathic membranous nephropathy.

Review 10. The Tao of myeloma.